The Clinical Observation of Cyclosporin A Combined with Stanozolol Used in Chronic Aplastic Anemia
Tao Wu
Abstract
Tao Wu
Abstract
Objective To observe the clinical effect of cyclosporin A combined stanozolol treated in chronic aplastic anemia(CAA).Methods All 52 cases chronic aplastic anemia were randomly divided into control group and observation group.Control group:a single treatment with stanozolol,the observation group were based on combined cyclosporine,to compare the efficacy of the two groups before and after treatment,and to observe the changes of peripheral blood neutrophils,hemoglobin,reticulocyte and platelet.Results The total efficiency of the observation group was 76.9%,it was higher than the control group(53.8%)(P0.05).After treatment,neutrophils,hemoglobin,reticulocytes,platelets was significantly improved and compared with before treatment,and the observation group was significantly improved than the control group(P0.05).Conclusion Cyclosporin A combined with stanozolol used in treatment of chronic aplastic anemia is reliable,safe,and it should be widely promoted and applications.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the clinical effect of cyclosporin A combined stanozolol treated in chronic aplastic anemia(CAA).Methods All 52 cases chronic aplastic anemia were randomly divided into control group and observation group.Control group:a single treatment with stanozolol,the observation group were based on combined cyclosporine,to compare the efficacy of the two groups before and after treatment,and to observe the changes of peripheral blood neutrophils,hemoglobin,reticulocyte and platelet.Results The total efficiency of the observation group was 76.9%,it was higher than the control group(53.8%)(P0.05).After treatment,neutrophils,hemoglobin,reticulocytes,platelets was significantly improved and compared with before treatment,and the observation group was significantly improved than the control group(P0.05).Conclusion Cyclosporin A combined with stanozolol used in treatment of chronic aplastic anemia is reliable,safe,and it should be widely promoted and applications.
Key concepts: Stanozolol, Medicine, Aplastic anemia, Hemoglobin, Reticulocyte, Gastroenterology, Internal medicine, Platelet